Description: Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.
Home Page: www.dcb-group.com
No.7 ChangBaiShan Road
Yantai,
264006
China
Phone:
86 53 5639 1521
Officers
| Name | Title |
|---|---|
| Ms. Chun Ping Zhu | Financial Director |
| Mr. Xing Hua Bai | Deputy Gen. Mang. |
| Ms. Hong Bo Xin | Deputy GM & Non-Independent Director |
| Mr. Zhi Gang Luo | Deputy GM & Non-Independent Director |
| Ms. Qiong Yi | Deputy Gen. Mang. |
| Dr. Zhen Qiu Yang | Deputy Gen. Mang. |
Exchange: SHE
Country: CN
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 70.5926 |
| Price-to-Book MRQ: | 2.7379 |
| Price-to-Sales TTM: | 3.6014 |
| IPO Date: | 2012-05-25 |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |